Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Synergy Pharmaceuticals Inc

+ Add to Watchlist

SGYP:US

4.3500 USD 0.0600 1.40%

As of 20:10:00 ET on 05/22/2015.

Company Profile for Synergy Pharmaceuticals Inc (SGYP)

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead drug candidate is a a guanylyl cyclase C (GC-C) receptor agonist, to treat gastrointestinal disorders, primarily chronic constipation and constipation-predominant irritable bowel syndrome (IBS-C).

Contact Information

Synergy Pharmaceuticals Inc

420 Lexington Avenue
Suite 1609
New York, NY 10170
United States
Phone: 1-212-297-0020
Fax: 1-212-297-0019

Key Executives for Synergy Pharmaceuticals Inc (SGYP)

Gary S JacobChairman/President/CEOPatrick H GriffinChief Medical Officer
Kunwar ShailubhaiExec VP/Chief Scientfic OfficerBernard F DenoyerSenior VP:Finance/Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil